1. Doubling the single-dose infusion rate of tocilizumab in rheumatoid arthritis is safe and efficacious. (3rd July 2016) Authors: Lindegaard, HM; Johansen, P; Gröndal, G; Jensen, EC; Juul, L; Schlemmer, AM; Agular, B; Hansen, IMJ Journal: Scandinavian journal of rheumatology Issue: Volume 45:Number 4(2016) Page Start: 262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Major reduction of ultrasound-detected synovitis during subcutaneous tocilizumab treatment: results from a multicentre 24 week study of patients with rheumatoid arthritis. (4th July 2021) Authors: Hammer, HB; Hansen, IMJ; Järvinen, P; Leirisalo-Repo, M; Ziegelasch, M; Agular, B; Terslev, L Journal: Scandinavian journal of rheumatology Issue: Volume 50:Number 4(2021) Page Start: 262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗